CD19 and breast carcinoma: Olkhanud et al. define a previously undescribed subpopulation of “tumor-evoked” CD19+ B220+ CD25+ B cells (named tBregs) that promotes the development of tumor metastasis in the lungs of a breast cancer mouse model (4T1) [28].